Perkins Capital Management Inc. has filed its Form 13F-HR for the period ending September 30, 2026, disclosing the firm's equity holdings as of that date. The filing lists the company's principal office at 730 East Lake Street in Wayzata, Minnesota.
The report details a portfolio of 87 individual equity securities. The largest position disclosed in the filing is 10x Genomics Inc., Class A common stock, for which the firm holds 2,259,000 shares. Other significant holdings include Airgain Inc. with 22,000 shares, Alphatec Holdings Inc. with 183,905 shares, and Ani Pharmaceuticals Inc. with 3,366 shares.
The filing also lists positions in major technology and healthcare companies. These include Apple Inc. with 2,650 shares, Abbott Laboratories with 20,257 shares, Advanced Micro Devices Inc. with 13,404 shares, and Eli Lilly & Co. with 8,680 shares. Other notable entries in the portfolio include Johnson & Johnson, Microsoft Corporation, Pfizer Inc., and Seagate Technology Holdings PLC.
The report lists Richard C. Perkins as the President of the firm and the contact person for the filing.
